http://www.business-standard.com/bsonline/storypage.php?bKeyFlag=BO&autono=9755
Ranbaxy's Goa plant gets MHRA approval
Our Web Bureau / Mumbai June 02, 2005
Ranbaxy Laboratories has announced that the company's manufacturing
facility in Goa has received approval from the Medicines and Healthcare
products Regulatory Agency (MHRA), UK for its tablets manufacturing unit.
According to the release issued by the company today, with this Ranbaxy
can now seek approvals in 27 member states and various other countries
like Australia, New Zealand, Romania etc. The Goa facility also houses a
cream and ointment manufacturing block.
Ranbaxy 's manufacturing capabilities at Goa were augmented recently to
cater to the growing global demand for the company's products.
Commenting on the development, Brian Tempest, CEO and managing director of
Ranbaxy said, "It is our endeavour to constantly expand and augment our
manufacturing capabilities across the globe to keep pace with the growing
international business of the Company. The Year 2004 witnessed concerted
efforts in this direction. This latest approval will allow us to use this
facility for manufacturing products for the EU and many other countries."
